New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses.

The results did not reach statistical significance due to the small study size and high variability in the indirect cost estimates, but the difference more than offset the estimated treatment cost of $US375 per year.

also in 111,027 other papers